Trials / Unknown
UnknownNCT02739529
Study to Evaluate the Efficacy and Safety of Genexol-PM Once a Week for Gynecologic Cancer
Dose-dense Paclitaxel (Genexol®-PM) Once a Week in Combination With Carboplatin Every 3 Weeks for Gynecologic Cancer (Adult Solid Tumor): a Phase I Trial
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- Samyang Biopharmaceuticals Corporation · Industry
- Sex
- Female
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
Dose-dense paclitaxel (Genexol®-PM) once a week in combination with carboplatin every 3 weeks for gynecologic cancer (adult solid tumor): a phase I trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Genexol-PM | Cremophor EL-free polymeric micelle of paclitaxel |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2018-03-01
- Completion
- 2018-03-01
- First posted
- 2016-04-15
- Last updated
- 2017-05-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02739529. Inclusion in this directory is not an endorsement.